There is no 10K yet for $TWST. Annual reports usually take a while. While we wait lets look at the company. They do $104 million in SynBio and about $104 million in NGS. These program continue to grow. They are the cash cows that pay the bills. They are very profitable.
Now $TWST is investing that money in developing the future with Biopharma and DNA storage. I skip the investments in DNA storage as I don't know if or how well it will work. I do know Biopharma as a long time biotech investor. So lets look at that.
They started Biopharma in 2019 to use their expertise in sequencing DNA and Bioinformatics to help companies design and develop antibodies. The antibody space is a $100 billion Total Addressable market.
Its like 10,000x bigger than SynBio and NGS and it will eventually dwarf all other segments of this company in a few years. Don't believe me? Here is a chart showing how quickly they grew Biopharma revenues in just a few short years.
They now have nearly $25 million in Biopharma revenues. They have 59 partnerships with 59 downstream milestones and royalties.
So not only are they getting paid for their work. They will eventually get royalty revenue streams years down the line. They added another 6 new partnerships in the Q4. This will be the huge opportunity that dwarfs all others.
Loading suggestions...